Merck & Co. Inc.

NYS : MRK
Pharmaceuticals
Whitehouse Station NJ
IW Best50N/A
2012 Revenue (US$ Millions)$47,267
2011 Revenue (US$ Millions)$48,047
Revenue Growth (%)-1.62%
Net Income (US$ Millions)$6,168
Common Shares Outstanding (Millions)$3,027
Earnings Per Share (US$)$2.00
Total Equity (US$ Millions)$53,020
Profit Growth (%)-1.66
Profit Margin (%)13.05%
Return On Equity (%)11.31%
Long Term Debt (US$ Millions)$16,254
Debt To Equity Ratio (%)0.31%
Market Capitalization (US$ Millions)$123,910
Total Assets (US$ Millions)$106,132
Return on Assets (%)5.87
Current Assets (US$ Millions)$34,857
Inventories (US$ Millions)$6,535
Current Liabilities (US$ Millions)$18,348
Cost of Goods Sold (US$ Millions)$16,446
Asset Turnover0.45
Inventory Turnover2.57